Ginkgo Bioworks Holdings (DNABW) Income from Non-Controlling Interests (2020 - 2022)

Ginkgo Bioworks Holdings (DNABW) reported Income from Non-Controlling Interests of $2.4 million for Q4 2022, up 155.08% on a YoY basis from $936954.3 in Q4 2021, and up 236.96% quarter-over-quarter from -$1.7 million in Q2 2022.

Ginkgo Bioworks Holdings (DNABW) Income from Non-Controlling Interests (2020 - 2022) Analysis & Trends

Ginkgo Bioworks Holdings has reported Income from Non-Controlling Interests for 3 years, with the latest figure at $2.4 million in Q4 2022.

  • For the quarter ending Q4 2022, Income from Non-Controlling Interests rose 155.08% year-over-year to $2.4 million; the trailing twelve-month figure through Sep 2023 stood at $2.4 million (up 129.25% YoY), and the FY2022 full-year result was -$1.4 million, up 78.12% from the prior year.
  • Income from Non-Controlling Interests for Q4 2022 stood at $2.4 million, up from -$1.7 million in the prior quarter.
  • The five-year high for Income from Non-Controlling Interests was $2.4 million in Q4 2022, with the low at -$4.3 million in Q4 2021.
  • Historically, Income from Non-Controlling Interests has averaged -$968888.9 across 3 years, with a median of -$753000.0 in 2020.
  • Annual changes were most pronounced in 2021 — Income from Non-Controlling Interests tumbled 838.03% — and 2022, when it surged 155.08%.
  • Ginkgo Bioworks Holdings' Income from Non-Controlling Interests stood at -$753000.0 in 2020, then tumbled by 476.23% to -$4.3 million in 2021, then surged by 155.08% to $2.4 million in 2022.
  • The last three Income from Non-Controlling Interests figures came in at $2.4 million (Q4 2022), -$1.7 million (Q2 2022), and -$2.1 million (Q1 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -13.75 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Ginkgo Bioworks Holdings - - 16.38 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2022 2.39 Mn
Jun 30, 2022 -1.75 Mn
Mar 31, 2022 -2.09 Mn
Dec 31, 2021 -4.34 Mn
Sep 30, 2021 -524,000.00
Jun 30, 2021 -523,000.00
Mar 31, 2021 -1.21 Mn
Dec 31, 2020 -753,000.00
Sep 30, 2020 71,000.00